#CICON24 wrapped up on September 11, 2024, in National Harbor, MD, showcasing breakthrough advancements that are set to transform cancer treatment. Discover 5 key takeaways from the conference, in our recap blog: bit.ly/47ss0nk #CancerResearch #Immunotherapy

Dr. Kevin Wang @Penn shares his excitement about attending and presenting at #CICON24, from the supportive atmosphere, to the cutting-edge research showcased, and the opportunities it has provided for collaboration and growth in the field of cancer immunotherapy. #Immunotherapy

Following her presentation on fibrolamellar hepatocellular carcinoma, CRI Clinical Innovator Dr. Marina Baretti @HopkinsMedicine sat down with the Cancer Research Institute to share how the scientific discoveries being discussed at #CICON24 have immediate, real world application.

CRI Lloyd J. Old STAR Dr. Ping-Chih Ho @PCHo_Lab of @unil @Ludwig_Cancer describes how the environment at #CICON24 naturally lends itself to collaboration and creative problem solving. #CancerResearch #Immunotherapy

"We're back with the next level- the next generation of science. Now, we have to take that science, and translate it into the next generation of immunotherapies," emphasizes CRI Scientific Advisory Council Associate Director Dr. Elizabeth Jaffee @HopkinsMedicine, at #CICON24.

Explore cancer vaccines, immune health, and future therapies in our recap blog of the sessions and discussions that took place during the second day of #CICON24! Read now: bit.ly/4ek9srJ #CancerResearch #Immunotherapy #CancerVaccines

During an exclusive interview from the second day of #CICON24, Dr. Andrew Koh from @UTSWMedCenter describes what excites him most about the current state of cancer immunotherapy! #Immunotherapy #CancerResearch

To young researchers at #CICON24 who are navigating their futures in the field of cancer research, @MSKCancerCenter's Dr. Dana Pe'er emphasizes, "You need to follow your passion, because passion drives ideas. Passion drives innovation." #CancerResearch #Immunotherapy

Understand why conferences such as #CICON24 are so critical for sharing scientific data and discoveries, according to Dr. Amanda Lund of @nyulangone @theLundLab, a 2019 CRI Lloyd J. Old STAR class member. #Immunotherapy #CancerResearch

Discover the groundbreaking research and collaboration that's driving the future of cancer immunotherapy, in our daily recap blog from the first day of #CICON24, presented by CRI and @ENCI_network, in conjunction with @C_IMT, EATI, NIBIT, and GÉTICA: bit.ly/47l3TXz

During the second session of #CICON24, CRI-Immuno-Informatics Fellow Dr. Qin Zhu @UCSF joined us to explore how machine learning and advanced technologies are allowing him study T cell state and identify mechanisms that can drive them to become effector T cells. #MachineLearning

During #CICON24's first session, @MSKCancerCenter's Dr. Luis Diaz Jr. dove into the groundbreaking potential of immunoablative neoadjuvant therapy, an approach that uses the power of the immune system to target and shrink tumors before surgery, offering new hope to patients.

The Eighth International Cancer Immunotherapy Conference kicks off this morning! Joining the Cancer Research Institute and @ENCI_network in National Harbor, MD today? Share your own photos and content from the conference, using the hashtag #CICON24 to be reposted!

Register by July 15, and save with early-bird discounts for #CICON24, presented by CRI and @ENCI_network, in conjunction with ENCI partner organizations, @C_IMT, EATI, NIBIT, and GÉTICA! Sign up to attend the conference, held from September 8-11, 2024: bit.ly/49Bceq8

Register today for #CICON24, presented by CRI and @ENCI_network, in conjunction with ENCI partner organizations, @C_IMT, EATI, NIBIT, and GÉTICA! Sign up to attend the conference, held September 8-11, 2024, in National Harbor, MD: bit.ly/49Bceq8 #CancerResearch #CICON